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Short Report
Acromelic frontonasal dysostosis and ZSWIM6
mutation: phenotypic spectrum and mosaicism
Twigg S.R.F., Ousager L.B., Miller K.A., Zhou Y., Elalaoui S.C., Sefiani A.,
Bak G.S., Hove H., Hansen L.K., Fagerberg C.R., Tajir M., Wilkie A.O.M.
Acromelic frontonasal dysostosis and ZSWIM6 mutation: phenotypic
spectrum and mosaicism.
Clin Genet 2016: 90: 270–275. © 2015 The Authors. Clinical Genetics
published by John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.,
2015
Acromelic frontonasal dysostosis (AFND) is a distinctive and rare
frontonasal malformation that presents in combination with brain and limb
abnormalities. A single recurrent heterozygous missense substitution in
ZSWIM6, encoding a protein of unknown function, was previously shown to
underlie this disorder in four unrelated cases. Here we describe four
additional individuals from three families, comprising two sporadic subjects
(one of whom had no limb malformation) and a mildly affected female with
a severely affected son. In the latter family we demonstrate parental
mosaicism through deep sequencing of DNA isolated from a variety of
tissues, which each contain different levels of mutation. This has important
implications for genetic counselling.
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Acromelic frontonasal dysostosis and ZSWIM6 mutation
Acromelic frontonasal dysotosis (AFND; MIM 603671)
is characterized by a combination of characteristic fron-
tonasal malformation (FNM) with limb defects and
anomalies of the brain and usually occurs as a spo-
radic disorder. Following initial description in a review
of the diverse presentations of FNM (1), Verloes et al.
proposed AFND as a distinct entity (2); subsequent
reports have highlighted characteristic features of severe
hypertelorism, ptosis, median cleft face with distinc-
tive nasal bifurcation and widely separated nasal alae,
parietal foramina, variable brain abnormalities includ-
ing dysgenesis of the corpus callosum, hydrocephalus
and interhemispheric lipoma, limb anomalies with preax-
ial polydactyly of the feet, tibial aplasia or hypopla-
sia, and talipes equinovarus (3–5). Although mainly
arising sporadically, possible vertical transmission (5)
suggested a dominant mechanism, subsequently con-
firmed by identification of the underlying heterozy-
gous mutation in four AFND cases (6). These four
cases were found to carry an identical mutation of
ZSWIM6 (MIM: 615951; c.3487C>T; p.Arg1163Trp),
all apparently de novo in origin. In one subject, a
reduced ratio of mutant to wild-type allele indicated
that the mutation was present in mosaic state and
had likely arisen post-zygotically; in another family,
mild phenotypic features in the father were speculated
to be caused by mosaicism, although no evidence of
ZSWIM6 mutation was found in the blood from this
individual (6).
We describe four additional cases of AFND carrying
the ZSWIM6 c.3487C>T variant. Limb anomalies, usu-
ally part of the AFND phenotype, were absent in one
case with a constitutive de novo mutation, establishing
that this is not an absolute requirement for diagnosis.
In a mildly affected parent we demonstrate mosaicism,
confirming that this mechanism can result in a milder
phenotype within the FNM spectrum.
Materials and methods
Subjects
The study was approved by Oxfordshire Research
Ethics Committee B (reference C02.143) and Riverside
Research Ethics Committee (reference 09/H0706/20);
written informed consent was obtained from all par-
ticipants by the referring clinicians. Karyotyping of
all subjects was normal; although array comparative
hybridisation (aCGH; Agilent 244K) in Subjects 1-1
and 1-2 showed a 3.2Mb duplication of 16p12.3-p13.1
that had arisen de novo in the mother, this appears to
be coincidental to the AFND phenotype. DNA was
extracted from peripheral blood samples (Subjects 1-1,
1-2, 2 and parents of Subjects 2 and 3), an aminiocen-
tesis sample (Subject 3), and buccal brushings, saliva,
urine and skin (Subject 1-1). The resequencing panel
consisted of 27 individuals with mild to severe FNMs,
with or without extracranial abnormalities, and lacking
a molecular diagnosis.
Molecular analysis
A 370 bp fragment covering the ZSWIM6 (Refseq
NT_034772.7) exon 14 c.3487C>T variant was ampli-
fied using primers E14F 5′-GCTATAATACCTCTGG
TGGTCAAGAGTG-3′ and E14R 5′-CCCGAACCAAC
ATCATCAGTTTC-3′. Amplification was carried with
0.5U of FastStart polymerase (Roche Diagnostics,
Burgess Hill, UK) in a total volume of 20 μl contain-
ing 15mM Tris–HCl (pH 8.0), 50mM KCl, 2.5mM
MgCl2, 100 μM each dNTP and 0.4 μMprimers. Cycling
conditions consisted of an 8min denaturation step at
94∘C, followed by 33 cycles of 94∘C for 30 s, 63∘C
for 30 s and 72∘C for 30 s, with a final extension at
72∘C for 10min. This product was sequenced using
BigDye Terminator v3.1 (Applied Biosystems, Foster
City, CA, USA). Deep sequencing on the Ion Torrent
PGM platform was used to quantify the proportions
of wild-type to mutant allele in genomic DNA. Frag-
ments of 220 bp spanning the c.3487C>T variant
were generated (ZSWIM6-specific primers: Exon14F
5′-GCCTACATCAACACAACGCACTCACGG-3′ and
Exon14R 5′-CATACAAGATCTATCAACCAAACCTC
TCCC-3′ with a 10 bp barcode incorporated into either
the reverse or forward oligonucleotide and flanked by
Ion Torrent P1 and A adapter sequences). The P1 and
A adapter sequences were flipped so that Ion Torrent
sequencing could be carried out in both directions. The
high-fidelity Taq polymerase Q5 (NEB, Hitchin, UK)
was used for amplification (0.02U/μl) in a reaction
volume of 25 μl containing 0.5 μM primers, 25mM
Tap-HCl (pH 9.3), 50mM KCl, 2mM MgCl2, 1mM
β-mercaptoethanol and 200 μM each dNTP. Cycling
was carried out as described above except the cycle
number was reduced to 30 and the annealing temper-
ature was 60∘C. Amplification products were purified
with AMPure beads (Beckman Coulter, High Wycombe,
UK) and emulsion polymerase chain reaction (PCR)
and enrichment performed with the Ion PGM Template
OT2 200 Kit (Life Technologies) according to the
manufacturer’s instructions. Sequencing of enriched
templates was performed on the Ion Torrent PGM (Life
technologies, Carlsbad, CA, USA) for 125 cycles using
the Ion PGM Sequencing 200 kit v2 on an Ion 316 chip.
Data were processed with Ion Torrent platform-specific
pipeline software v4.2.1. As the variant must be present
at a level of 50% in a heterozygous individual, and at
0% in a normal control, the forward and reverse deep
sequencing read counts were separately normalized
using the data from Subject 1-2 and a control, and the
average of the two corrected percentages calculated.
Results
Clinical description
The clinical features of Subjects 1-1, 1-2, 2 and 3 are
summarized in Table 1 and shown in Figure 1. Sub-
ject 1-2 was born at 32 weeks’ gestation (birth weight:
1580 g) and diagnosed with AFND due to the association
of severe FNM and limb abnormalities. Currently aged
7 years, he has severe neurocognitive and motor delay
271
Twigg et al.
Ta
bl
e
1.
C
lin
ic
al
fe
at
ur
es
of
su
bj
ec
ts
w
ith
ZS
W
IM
6
c.
34
87
C
>
T;
p.
A
rg
11
63
Tr
p
C
ra
ni
of
ac
ia
l
B
ra
in
S
ub
je
ct
#
G
en
de
ra
E
ye
s
N
os
e
M
ou
th
S
ku
ll
M
or
ph
ol
og
y
D
ev
el
op
m
en
t
Li
m
bs
O
th
er
1-
1b
F
H
yp
er
te
lo
ris
m
W
id
e
na
sa
lb
rid
ge
,
sh
or
tn
as
al
rid
ge
,
bi
ﬁd
na
sa
lt
ip
N
or
m
al
N
or
m
al
N
or
m
al
N
or
m
al
N
or
m
al
–
1-
2
M
S
ev
er
e
hy
pe
rt
el
or
is
m
,
do
w
ns
la
nt
in
g
pa
lp
eb
ra
lﬁ
ss
ur
es
W
id
e
na
sa
lb
rid
ge
,
w
id
el
y
sp
ac
ed
na
sa
la
la
e,
w
id
el
y
se
pa
ra
te
d
sl
it-
lik
e
na
re
s
C
ar
p-
sh
ap
ed
m
ou
th
,m
id
lin
e
no
tc
h
in
up
pe
r
lip
,
cl
ef
tp
al
at
e
B
on
y
de
fe
ct
of
an
te
rio
r
cr
an
ia
l
fo
ss
a,
pa
rie
ta
l
fo
ra
m
in
a
In
te
rh
em
is
ph
er
ic
lip
om
a,
pa
rt
ia
l
ag
en
es
is
of
th
e
co
rp
us
ca
llo
su
m
S
ev
er
e
m
ot
or
an
d
ne
ur
oc
og
ni
tiv
e
de
la
y
N
or
m
al
up
pe
r
lim
bs
,b
ila
te
ra
lt
ib
ia
l
he
m
im
el
ia
,b
ila
te
ra
l
bi
ﬁd
ﬁr
st
to
e,
bi
la
te
ra
lc
lu
bf
oo
t
–
2
M
H
yp
er
te
lo
ris
m
,
bi
la
te
ra
lp
to
si
s,
do
w
ns
la
nt
in
g
pa
lp
eb
ra
lﬁ
ss
ur
es
,
bi
la
te
ra
lc
at
ar
ac
t
W
id
e
na
sa
lb
rid
ge
,
sh
or
tn
as
al
rid
ge
,
bi
ﬁd
na
sa
lt
ip
,
w
id
el
y
sp
ac
ed
na
sa
la
la
e,
w
id
el
y
se
pa
ra
te
d
sl
it-
lik
e
na
re
s
C
ar
p-
sh
ap
ed
m
ou
th
,l
on
g
ph
ilt
ru
m
,m
id
lin
e
no
tc
h
in
up
pe
r
lip
,
cl
ef
tp
al
at
e
B
on
y
de
fe
ct
of
an
te
rio
r
cr
an
ia
l
fo
ss
a
A
nt
er
io
r
in
te
rh
em
is
ph
er
ic
lip
om
a
S
ev
er
e
ps
yc
ho
m
ot
or
de
la
y,
ab
se
nc
e
of
sp
ee
ch
,
do
es
no
tw
al
k
ag
ed
8
ye
ar
s
N
or
m
al
M
ic
ro
pe
ni
s,
cr
yp
to
rc
hi
di
sm
,
sc
ol
io
si
s
3c
F
H
yp
er
te
lo
ris
m
,
do
w
ns
la
nt
in
g
pa
lp
eb
ra
lﬁ
ss
ur
es
A
pl
as
ia
/h
yp
op
la
si
a
of
th
e
na
sa
lb
on
es
,
w
id
e
na
sa
lb
rid
ge
,
bi
ﬁd
na
sa
lt
ip
M
id
lin
e
no
tc
h
in
up
pe
r
lip
–
–
–
N
or
m
al
up
pe
r
lim
bs
,b
ila
te
ra
lt
ib
ia
l
hy
po
pl
as
ia
,b
ila
te
ra
l
cl
ub
fo
ot
–
a
F,
fe
m
al
e,
M
,m
al
e.
b
M
os
ai
c
fo
r
th
e
m
ut
at
io
n.
c
P
re
gn
an
cy
te
rm
in
at
ed
at
20
w
ee
ks
’g
es
ta
tio
n.
272
Acromelic frontonasal dysostosis and ZSWIM6 mutation
Fig. 1. Clinical features of individuals with ZSWIM6 c.3487C>T mutations. (a) Subject 1-1 showing facial features at about 1 year of age. Note
hypertelorism and bifid nasal tip. (b,c) Neonatal appearance of Subject 1-2, with severe FNM, hypertelorism, carp-shaped mouth with notch in upper
lip (b), and bifid great toes and clubfoot (c). (d) Brain magnetic resonance imaging of Subject 2 showing interhemispheric lipoma (white arrow),
and severe hypertelorism. (e,f) Ultrasound images of Subject 3 showing orbital hypertelorism (e, arrows indicate the eyes) and hypoplastic nose (f,
arrowhead). (g) Clinical appearance of Subject 3 with FNM, hypertelorism and clubfoot. Polydactyly is absent.
and is unable to walk and communicate with words. His
mother, Subject 1-1, who had undergone numerous sur-
gical procedures to reshape the frontonasal region, was
suspected to have amilder form of the same disorder. She
has hypertelorismwith a short, broad nose and bifid nasal
tip, but normal intelligence and no extracranial features.
Subject 2, the third of four children born to unrelated and
unaffected parents, is a 12-year-old boy with severe psy-
chomotor delay who was not diagnosed with AFND due
to absence of limb abnormalities. Extracranially he had
scoliosis, cryptorchidism and micropenis. Subject 3 was
a female fetus with abnormalities detected by ultrasound
at 19+ 3weeks’ gestation, including facial malformation
with hypertelorism and broad glabella, nasal hypoplasia
and bilateral talipes equinovarus. Following elective ter-
mination of pregnancy, postnatal examination revealed
features in keeping with a diagnosis of AFND, includ-
ing median facial cleft and bilateral tibial hypoplasia,
although polydactyly was absent. No other family mem-
bers had similar abnormalities.
Molecular analysis
Screening for ZSWIM6 c.3487C>T in a cohort of 27
FNM cases revealed the presence of this variant in three
individuals, Subjects 1-2, 2 and 3 (Fig. 2a). The ratio
of mutant to wild-type allele was approximately 50:50
in each case. As the variant was not detected in blood
from Subject 1-1, the mildly affected mother of Subject
1-2 and in whom mosaicism was suspected, we ana-
lyzed DNA from four other tissues (buccal brushings,
saliva, skin and urine). Sanger sequencing was incon-
clusive although a subtle drop in peak height of the
wild-type allele was evident in the two buccal samples,
suggesting the presence of the variant allele (data not
shown). This prompted us to undertake more sensitive
Ion Torrent-based deep sequencing, which identified the
mutant variant in all five tissue samples from Subject 1-1
(Fig. 2b). The average sequencing depth obtained was
>152,800 with a lowest read number of 55,173. The per-
centage of variant allele was highest at ∼11% in the buc-
cal scrapings (equivalent to∼22%mutant cells), at 3% in
saliva, around 2% in urine and blood and lowest at under
1% in skin. The sensitivity of mutation detection using
Sanger sequencing is around 6% (7) providing an expla-
nation for why testing of DNA from peripheral blood of
Subject 1-1 was negative.
Discussion
AFND is an extremely rare FNM with fewer than
20 recognizable cases described in the literature (1,
273
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Fig. 2. ZSWIM6 sequence analysis. (a) Sequence chromatograms showing ZSWIM6 c.3487C>T in Subjects 1-2, 2 and 3 (red arrows). The C>T variant
is absent in Subject 1-1 (DNA from peripheral blood) and the parents of Subjects 2 and 3. (b) Deep sequence analysis for ZSWIM6 c.3487C>T. The
left hand panel shows the percentage of the variant T allele detected in Subject 1-1 and 1-2. The value for Subject 1-2 has been corrected to 50% and
all other figures adjusted accordingly. The T allele is shown in red and the C allele in blue. The right hand panel shows the uncorrected read depths
achieved for each sample.
2, 4–6, 8–10). The most consistent clinical features
are FNM accompanied by preaxial polydactyly of the
lower limbs. The nasal deformity is usually severe,
with symmetrical clefting and widely separated slit-likes
nares, while limb anomalies can also include tibial
hypoplasia and clubfoot. Recently, a recurrent mutation
of ZSWIM6, c.3487C>T encoding p.Arg1163Trp, was
identified in four AFND individuals (6). ZSWIM6 is a
member of a group of proteins, found in bacteria, archaea
and eukaryotes, that all contain a SWIM Zn-finger-like
domain that could function both as a DNA binding
domain or in protein–protein interaction (11). Very
little is known about the role of ZSWIM6, although
the missense substitution identified in AFND is likely
to disrupt the function of a highly conserved sin3-like
domain at the C-terminus of the protein (6). Expression
appears to be ubiquitous although higher in the brain,
and analysis of AFND patient cells suggests an effect
on hedgehog signaling (6). A molecular-developmental
explanation for the specific pattern of malformations
occurring in AFND is currently lacking.
In this report we screened a phenotypically diverse
FNM cohort for this variant and identified three positive
individuals, all of whom shared the characteristic nose
with symmetrical, widely separate nostril openings and
severe hypertelorism (Fig. 1b,e). This included a previ-
ously undiagnosed patient with severe FNM but normal
limbs. A confident diagnosis of AFNDwith normal limbs
has only been possible in one previous case, one of the
two half-sisters reported by Warkany et al. (10), where
a diagnosis could be made because of the classically
affected relative. Our findings imply that similar cases
with isolated severe symmetrical FNM should undergo
ZSWIM6 screening. Interestingly, although Subject 3 had
lower limb abnormalities, polydactyly was absent, high-
lighting that this featuremay not always be present either.
Although mosaicism had been suspected in the mildly
affected parent of a classical AFND patient (6), it was not
molecularly confirmed. We prove, through next genera-
tion deep sequencing of DNA from multiple tissues, that
mosaicism can occur in the mildly affected parents of
AFND cases. Notably, the low level of mosaicism found
could not be convincingly detected by Sanger sequenc-
ing, even of multiple tissues. The use of PCR-based or
capture techniques combined with next generation deep
274
Acromelic frontonasal dysostosis and ZSWIM6 mutation
sequencing is an effective method to identify low fre-
quencymosaicmutations that aremissed by conventional
techniques (12, 13). In our analysis deep sequencing
allowed the convincing detection of mutations at less
than a 2% level. The finding of mosaicism has important
counselling implications for AFND families and the pos-
sibility of mosaicism in one of the parents of a child with
a germline mutation, whether they are mildly affected or
appear normal, should be considered. The phenotype of
Subject 1-1 shows similarities to frontorhiny, a distinct
FNM caused by biallelic mutations of ALX3 (14). We
propose that for patients thought to have frontorhiny, but
with a negative ALX3 mutation screen, the possibility of
low-level mosaicism for the ZSWIM6 mutation should
be sought by deep sequencing of multiple tissues.
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